Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Please provide your email address to receive an email when new articles are posted on . When given a choice, participants preferred fecal immunochemical test-based screening for colorectal cancer ...

With the backlog of NHS patients awaiting colonoscopy for suspected bowel cancer currently approaching 100,000 and increasing month-on-month, researchers have suggested that a temporary partial fix ...

Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...

ASCs are increasingly at the forefront of colorectal cancer prevention efforts, particularly as new screening technologies gain traction. Following two FDA approvals last year, many ASCs are stepping ...

More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...

Eleven years ago, my life was forever changed when I lost my beloved husband, Len Atkins, to colorectal cancer. He was only 48, a time when most people wouldn't even consider a colonoscopy. It's a ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

Sensitivity varied from 10.1 to 36.7%, and specificity varied from 85.5 to 96.6% for advanced colorectal neoplasia. HealthDay News — Fecal immunochemical tests (FITs) have variable sensitivity and ...

The National Institute for Health and Care Excellence (NICE) has issued advice to GPs that all patients with signs or symptoms suspicious of colorectal cancer be offered a faecal immunochemical test ...